Posted in | News | Gold | Mining Business

AuEx Ventures Receives Shareholders Approval for Plan of Arrangement with Fronteer Gold

AuEx Ventures, Inc. (TSX:XAU) has announced that an overwhelming majority of AuEx shareholders who voted today at AuEx's Annual and Special Meeting of Shareholders have voted to approve the plan of arrangement pursuant to which Fronteer Gold Inc. (TSX:FRG)(NYSE Amex:FRG) will acquire all the issued and outstanding common shares of AuEx.

Over 99.95% of the securities voted at the Meeting were voted in favor of the special resolution approving the Arrangement.

Under the Arrangement, AuEx shareholders will receive 0.645 of a Fronteer Gold common share, Cdn$0.66 in cash, and 0.5 of a share in Renaissance Gold, Inc. ("RenGold"), a new exploration company, for each AuEx share held. RenGold will hold all of AuEx's exploration assets outside of the Pequop District and have approximately Cdn$5.0 million in cash. On completion of the Arrangement, AuEx shareholders will hold 18.6% of pro forma outstanding shares of Fronteer Gold, on a fully-diluted basis and 90.1% of the RenGold shares, while Fronteer Gold will hold the remaining 9.9% of the RenGold shares.

The TSX Venture Exchange has conditionally approved the listing of the RenGold shares on a date to be determined following completion of the Arrangement.

AuEx's application to the Supreme Court of British Columbia to obtain the final court order approving the Arrangement is scheduled for Monday, November 1, 2010. Assuming court approval is obtained and that all other conditions to the Arrangement are satisfied or waived, the Arrangement is expected to become effective on or about November 3, 2010.

Source:

AuEx Ventures, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.